Wells Fargo
LLY icon

Wells Fargo’s Eli Lilly LLY Stock Holding History

Wells Fargo’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$472M Sell
512,700
-6,100
-1% -$6.18M 0.09% 212
2025
Q4 		$558M Sell
518,800
-134,900
-21% -$129M 0.1% 178
2025
Q3 		$499M Buy
653,700
+199,600
+44% +$149M 0.09% 185
2025
Q2 		$354M Sell
454,100
-32,000
-7% -$24.9M 0.07% 233
2025
Q1 		$401M Sell
486,100
-47,100
-9% -$39.2M 0.09% 207
2024
Q4 		$412M Buy
533,200
+89,100
+20% +$73.8M 0.09% 193
2024
Q3 		$393M Buy
444,100
+109,000
+33% +$98M 0.09% 203
2024
Q2 		$303M Buy
335,100
+41,400
+14% +$33.1M 0.07% 225
2024
Q1 		$228M Buy
293,700
+152,800
+108% +$109M 0.06% 281
2023
Q4 		$82.1M Buy
140,900
+132,200
+1,520% +$77.2M 0.02% 541
2023
Q3 		$4.67M Sell
8,700
-2,700
-24% -$1.39M ﹤0.01% 2159
2023
Q2 		$5.35M Buy
11,400
+3,600
+46% +$1.51M ﹤0.01% 2095
2023
Q1 		$2.68M Buy
7,800
+6,900
+767% +$2.33M ﹤0.01% 2631
2022
Q4 		$329K Sell
900
-9,100
-91% -$3.23M ﹤0.01% 3893
2022
Q3 		$3.23M Buy
+10,000
New +$3.17M ﹤0.01% 2333
2022
Q1 		– Sell
-39,600
Closed -$10.9M – 7491
2021
Q4 		$10.9M Sell
39,600
-62,800
-61% -$15.9M ﹤0.01% 1791
2021
Q3 		$23.7M Buy
102,400
+77,400
+310% +$19.1M 0.01% 1536
2021
Q2 		$5.74M Buy
+25,000
New +$5.02M ﹤0.01% 2739
2020
Q4 		– Sell
-5,000
Closed -$5K – 6779
2020
Q3 		$5K Buy
+5,000
New +$774K ﹤0.01% 6020
2018
Q2 		– Sell
-10,000
Closed -$42K – 6457
2018
Q1 		$42K Hold
10,000
– – ﹤0.01% 5619
2017
Q4 		$28K Buy
+10,000
New +$851K ﹤0.01% 5704
2017
Q1 		– Sell
-13
Closed -$2K – 6404
2016
Q4 		$2K Buy
+13
New +$968 ﹤0.01% 6095
2015
Q3 		– Sell
-400
Closed -$1K – 6329
2015
Q2 		$1K Buy
+400
New +$30.5K ﹤0.01% 6239

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wells Fargo's LLY Position: Q1 2026 in Review

Wells Fargo increased its Eli Lilly (LLY) stake by 1.7% in Q1 2026, buying an estimated $74.2M and bringing the position to 4,405,844 shares worth $4.05B. The position accounts for 0.76% of the portfolio, ranked #19.

Wells Fargo first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.66B in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Wells Fargo held 4,405,844 shares of Eli Lilly worth $4.05B as of Q1 2026.
  • Wells Fargo bought 73,189 Eli Lilly shares in Q1 2026, an estimated $74.2M.
  • Eli Lilly made up 0.76% of Wells Fargo's portfolio in Q1 2026, its #19 holding.
  • Wells Fargo first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Wells Fargo's Eli Lilly position peaked at $4.66B in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.